Cialis

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
The phosphodiesterase 5 (PDE5) inhibitors, including sildenafil (Viagra™), vardenafil (Levitra™), and tadalafil (Cialis™) have… (More)
  • figure 1
  • figure 2
Is this relevant?
2013
2013
In this work, the chemical profile of 43 commercial samples of tablets for male erectile dysfunction (Viagra, Cialis, Lazar… (More)
Is this relevant?
2008
2008
Counterfeit and/or imitation medicines are becoming a major health problem not only in developing countries but also in wealthier… (More)
  • table 1
  • table 2
  • figure 1
  • figure 3
  • table 3
Is this relevant?
2006
2006
PURPOSE Erectile dysfunction after three-dimensional conformal external-beam radiotherapy (3DCRT) for prostatic carcinoma is… (More)
Is this relevant?
2006
2006
Methods of physiological energetics were applied to compare growth rates of mussels Mytilus galloprovincialis Lmk from 2 habitats… (More)
Is this relevant?
2005
2005
A 66-year-old male presented to our department with recurrent epistaxis. On examination it was not possible to identify the… (More)
Is this relevant?
2004
2004
OBJECTIVE Tadalafil (Cialis) is an inhibitor of phosphodiesterase type 5, which mediates relaxation of vascular smooth muscle in… (More)
Is this relevant?
Review
2002
Review
2002
  • H. Porst
  • International Journal of Impotence Research
  • 2002
IC351 (tadalafil, trade name Cialis) is a new representative compound of the second generation of selective phosphodiesterase 5… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2001
Highly Cited
2001
IC351 (Cialis™) is a selective inhibitor of PDE5. The efficacy and safety of on-demand dosing of IC351 in men with erectile… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?